Qualigen Therapeutics
Stock Forecast, Prediction & Price Target
Qualigen Therapeutics Financial Estimates
Qualigen Therapeutics Revenue Estimates
Qualigen Therapeutics EBITDA Estimates
Qualigen Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $5.65M N/A | $4.98M -11.85% | $5.20M 4.43% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
Net Income
% change YoY
| $-17.89M N/A | $-21.03M -17.53% | $-13.41M 36.21% | Avg: $-11.4M Low: $-3.60M High: $-3.60M avg. 15.03% | |||
EBITDA
% change YoY
| $-27.04M N/A | $-14.23M 47.37% | $-11.30M 20.61% | Avg: $0 Low: $0 High: $0 avg. 100% | |||
EPS
% change YoY
| -$6.1 N/A | -$5.48 10.16% | -$2.46 55.10% | Avg: -$0.71 Low: -$0.71 High: -$0.71 avg. 71.13% | |||
Operating Expenses
% change YoY
| $23.98M N/A | $18.62M -22.35% | $6.09M -67.26% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Qualigen Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 15.03% in 2025-2025.
We have gathered data from 1 analysts. Their low estimate is -3.60M, average is -11.4M and high is -3.60M.
What is Qualigen Therapeutics stock revenue growth forecast?
We have gathered data from 1 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Qualigen Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 71.13% in 2025-2025.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.71, average is -$0.71 and high is $-0.71.